3M to supply and distribute TSO3’s STERIZONE 125L+ Sterilizer TSO3 Inc. and 3M today announced that an contract has been reached for 3M to be the exclusive supplier and distributor of TSO3’s STERIZONE 125L+ Sterilizer. The partnership with TSO3, an innovator in low temp sterilization technology for medical products in healthcare settings through the use of ozone, includes new cycles to reach acute care facilities through 3M’s global sales channel. This agreement, combined with recent improvements to the sterilizer functionality in both cycle device and time compatibility, represents a significant part of the move to accelerate the product’s adoption in the global market.Obese white men were at greatest risk of having low testosterone amounts. Related StoriesCornell biomedical engineers develop 'super natural killer cells' to destroy cancers cells in lymph nodesNew results reveal association between colorectal cancer and melanoma medication treatmentViralytics enters into medical trial collaboration contract with MSDCOG guidelines suggest survivors treated with cranial irradiation have their pituitary function checked annually. Chemaitilly said the raised %age of survivors with previously undiagnosed hormone deficiencies highlights the necessity for new strategies to ensure survivors receive suggested health checks. St. Jude is definitely testing a pilot program to greatly help survivors at risk for endocrine complications changeover seamlessly from pediatric to adult treatment.